期刊文献+

二甲双胍联合达英-35治疗多囊卵巢综合征后促排卵药物的效果 被引量:2

下载PDF
导出
摘要 目的:观察二甲双胍联合达英-35(炔雌醇环丙孕酮片)治疗多囊卵巢综合征后促排卵药物的效果。方法:选取2012年3月至2014年8月收治100例多囊卵巢综合征患者作为研究对象,根据治疗方法分为观察组和对照组,每组各50例。观察组患者采用二甲双胍联合达英-35进行治疗;对照组患者单纯予以达英-35进行治疗。对比治疗后两组患者的体质量、腰臀比(waist-to-hip ratio,WHR)、身体质量指数(body mass index,BMI)、性激素及促排卵率、妊娠率的变化。结果:观察组和对照组患者在治疗3个月后体质量、BMI、WHR均有所下降,观察组下降程度比对照组更明显(P<0.05);与治疗前比较,两组性激素水平均有所降低,观察组比对照组下降更明显(P<0.05);治疗后组间比较差异也具有统计学意义(P<0.05)。结论:采用二甲双胍联合达英-35治疗多囊卵巢综合征,可降低患者性激素水平,增强多囊卵巢综合征对促排卵药物的敏感性,改善患者内分泌状况,从而达到治疗疾病的效果。
作者 李艳琼
出处 《包头医学院学报》 CAS 2016年第4期64-65,共2页 Journal of Baotou Medical College
  • 相关文献

参考文献4

二级参考文献29

  • 1胡敏,侯丽辉,吴效科.瘦素与多囊卵巢综合征的研究进展[J].中国妇幼健康研究,2006,17(2):125-128. 被引量:9
  • 2Oalle F,Azziz R.Insulin resistance,polycystic ovary syndrome,and type 2 diabetes mellitus.Fertil Steril,2002,77(6):1095-1105.
  • 3The Rotterdann ESHRE/ASRM-sponsored PCOS Consensus Workshop Group.Revised 2003 consensus on diagnostic criteria and longterm health risks related to polycystic ovary syndrome.Fertil Steril,2004,81(1):19-25.
  • 4Renato P,Alessandra G.Insulin-sensitizing agents in polycystic ovary syndrome.Eur J Endocrinol,2006,154(6):763-775.
  • 5Falsetti L,GamberaA.Tisi G.Efficiacy d the combination ethlnyl oestradiol and cyproterone acetate on endocrine,clinical and ultrasonographic profile in polycystic ovarian syndrome.Hum Reprod,2001,16(1):36-42.
  • 6Gostello MF,Fden JA.A systematic review of the reproductive system effects of metformin in patients with polycystic ovary syndrome.Fertil Steril,2003,79(1):1-13.
  • 7Glueck CJ,Goldenberg N,Pronikoff J,et al.Height,weight,and motor-social development during the first18 months of life in 126 infants bom to 109 mothers with palycystic ovary syndrome who conceived on and continued metformin through pregnancy.Hum Reprod,2004,19(6):1323-1330.
  • 8Coviello AD, Legro RS, Dunaif A. Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance [ J].J Clin Endocrinol Metab, 2006,91 (2) :492 - 497.
  • 9Sir-Petermann T,Maliqueo M,Codner E, et al. Early metabolic derangements in daughters of women with polycystic ovary syndrome [ J ]. Clin Endocrinol Metab, 2007,92 ( 12 ) : 4637 - 4642.
  • 10Cagnacci A, Paoletti AM. Glucose metabolism and insulin resistance in women with polycystic ovary syndrome during therapy with oral contraceptives containing cyproterone acetate or desogestrel [ J 1. J Clin Endocrinol Metab, 2003,88 (8) :3621 - 3625.

共引文献146

同被引文献19

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部